LexaGene anticipates changing the pathogen detection landscape by providing a customizable sample-to-answer instrument that is more rapid and sensitive than anything available to date. Led by experienced management and accomplished scientists, LexaGene aims to transform the way pathogen testing is performed by multi-billion dollar industries such as food safety, veterinary diagnostics, water quality management, aquaculture farming, and more.
- LexaGene’s breakthrough technology was invented by its founder, a lead scientist in developing predecessor instruments adopted by US Government for bio-warfare surveillance and supported by over $20M USD in funding
- $17.8 Billion+ USD market opportunity
- Applicable to multiple multi-billion dollar industries; including food safety testing where recent FDA changes create a market-changing opportunity
- Breakthrough technology with R&D risk mitigated
- Patent protected IP
- Equity structure managed to maximize shareholder value
- Listed on OTCQB as LXXGF and TSX.V as LXG
LexaGene on Fox Biz TV
LexaGene was featured on an episode of Innovations with Ed Begley Jr. which aired on Fox Business Network Saturday 26 August and 9 September @ 5pmET. Learn more about LexaGene by watching the segment.
6 February 2018 – LexaGene leases larger space to support company growth. The Company has significantly expanded its operations in Massachusetts and key new hires.
We are commercializing the first ‘open-access’ instrument for pathogen detection, allowing users an on-site instrument to target any gene sequence of interest, and return results in about an hour.
Food Engineering News
Food Engineering news magazine featured LexaGene in a recent article, interviewing Dr. Jack Regan about how LexaGene’s rapid-testing technology can impact the food processing market and enhance food safety.
Introducing the LX6
At a recent conference, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market. Watch Dr. Regan demonstrate the capabilities of LexaGene’s automated pathogen detection system.
LexaGene on The Street
Investment news outlet, The Street, speaks to LexaGene about its revolutionary pathogen detection system, and the company’s plans.
Subscribe to Updates
Stay informed about the latest LexaGene developments
LexaGene’s automated instrument quickly detects multiple pathogens with sensitivity and specificity. The platform is anticipated to transform the way food safety, aquaculture pathogen surveillance, water quality monitoring, and other markets get critical answers in less time.
- Fast results
- Can be used by anyone
- Screen for any pathogen
- Extreme sensitivity
- Low cost per test
- Compact design
LexaGene’s experienced leadership team is driving company growth with a focus on innovation, pursuing unique market opportunities, and providing shareholder value.